Persistence of Immunity to Varicella in Children with Leukemia Immunized with Live Attenuated Varicella Vaccine
- 6 April 1989
- journal article
- research article
- Published by Massachusetts Medical Society in New England Journal of Medicine
- Vol. 320 (14) , 892-897
- https://doi.org/10.1056/nejm198904063201403
Abstract
To determine the safety and efficacy of varicella vaccine, we studied 437 children in remission from leukemia who were immunized with live attenuated varicella virus. Three hundred one of the patients received two doses of vaccine and 136 received a single dose of vaccine from 1 of 10 lots from two manufacturers. The patients have been followed for an average of three years (range, one to six).This publication has 22 references indexed in Scilit:
- Western Blot Analysis of Antibody to Varicella-Zoster VirusThe Journal of Infectious Diseases, 1988
- The Risk of Zoster after Varicella Vaccination in Children with LeukemiaNew England Journal of Medicine, 1988
- Varicella Vaccine Licensing in 18 to 24 Months?Published by American Medical Association (AMA) ,1987
- Live Attenuated Varicella VaccineJAMA, 1984
- Live Attenuated Varicella Virus VaccineNew England Journal of Medicine, 1984
- Antibody Response to Varicella-Zoster Virus after Natural or Vaccine-Induced InfectionThe Journal of Infectious Diseases, 1982
- Restriction endonuclease analysis of varicella‐zoster vaccine virus and wild‐type dnasJournal of Medical Virology, 1982
- Serologic Response to Varicella-Zoster Membrane Antigens Measured by Indirect ImmunofluorescenceThe Journal of Infectious Diseases, 1974
- LIVE VACCINE USED TO PREVENT THE SPREAD OF VARICELLA IN CHILDREN IN HOSPITALPublished by Elsevier ,1974
- Modification of Chicken Pox in Family Contacts by Administration of Gamma GlobulinNew England Journal of Medicine, 1962